As both iatrogenic and experimental transmission of Creutzfeldt-Jakob disea
se (CJD) have been demonstrated, potential blood transfusion-related CJD th
rough blood component contamination is not unlikely. Recent studies also su
ggest that B lymphocytes would play a crucial role in the disease pathogene
sis. However, to date, there is no epidemiological evidence suggesting that
classical transmission of CJD would involve B lymphocytes. To reduce the t
heoretical risk of such transmission and as no biological marker of the dis
ease is currently available, at-risk blood donors are excluded and leukocyt
e depletion has been introduced. Furthermore, the recent discovery of a new
variant of the disease (nwCJD) which is caused by the bovine agent and has
typical tropism for lymphoreticular tissues should lead to close surveilla
nce. (C) 1999 Elsevier, Paris.